Familial coaggregation of alzheimer's disease and Parkinson's disease: Systematic review and meta-analysis

Neuroepidemiology

Volumn 42, Issue 2, 2014, Pages 69-80

  Feldman, Adina L ^a   Johansson, Anna L V ^a   Lambert, Paul C ^a,b   Sieurin, Johanna ^a   Yang, Fei ^a   Pedersen, Nancy L ^a,c   Wirdefeldt, Karin ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

^b UNIVERSITY OF LEICESTER   (United Kingdom)

^c UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

Alzheimer disease; Familial aggregation; Meta analysis; Parkinson disease; Systematic review

Indexed keywords

ALZHEIMER DISEASE; FAMILIAL DISEASE; FAMILY HISTORY; FIRST DEGREE RELATIVE; GENETIC RISK; HUMAN; META ANALYSIS; PARKINSON DISEASE; QUALITY CONTROL; REVIEW; RISK FACTOR; SYSTEMATIC REVIEW; COMORBIDITY; FAMILY HEALTH; AMYOTROPHIC LATERAL SCLEROSIS; DEMENTIA; DEPRESSION; DIFFUSE LEWY BODY DISEASE; DISEASE ASSOCIATION; PARKINSONISM; PROGRESSIVE SUPRANUCLEAR PALSY;

ALZHEIMER DISEASE; COMORBIDITY; FAMILY HEALTH; HUMANS; PARKINSON DISEASE; RISK FACTORS;

EID: 84896736419     PISSN: 02515350     EISSN: 14230208     Source Type: Journal    
DOI: 10.1159/000355452     Document Type: Review

References (39)

1. Aarsland D, Kurz MW: The epidemiology of dementia associated with Parkinson disease. J Neurol Sci 2010; 289: 18-22.
2. McKeith IG, Galasko D, Kosaka K, Perry EK, Dickson DW, Hansen LA, Salmon DP, Lowe J, Mirra SS, Byrne EJ, Lennox G, Quinn NP, Edwardson JA, Ince PG, Bergeron C, Burns A, Miller BL, Lovestone S, Collerton D, Jansen EN, Ballard C, de Vos RA, Wilcock GK, Jellinger KA, Perry RH: Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): report of the Consortium on DLB International Workshop. Neurology 1996; 47: 1113-1124.
3. Litvan I, Agid Y, Calne D, Campbell G, Dubois B, Duvoisin RC, Goetz CG, Golbe LI, Grafman J, Growdon JH, Hallett M, Jankovic J, Quinn NP, Tolosa E, Zee DS: Clinical research criteria for the diagnosis of progres - sive supranuclear palsy (Steele-Richardson-Olszewski syndrome): report of the NINDSSPSP international workshop. Neurology 1996; 47: 1-9.
4. Thacker EL, Ascherio A: Familial aggregation of Parkinson's disease: a meta-analysis. Mov Disord 2008; 23: 1174-1183.
5. van Duijn CM, Clayton D, Chandra V, Fratiglioni L, Graves AB, Heyman A, Jorm AF, Kokmen E, Kondo K, Mortimer JA, Rocca WA, Shalat SL, Soininen H, Hofman A, et al: Familial aggregation of Alzheimer's disease and related disorders: a collaborative re-analysis of case-control studies. Int J Epidemiol 1991; 20(suppl 2):S13-S20.
6. Amaducci LA, Fratiglioni L, Rocca WA, Fieschi C, Livrea P, Pedone D, Bracco L, Lippi A, Gandolfo C, Bino G, et al: Risk factors for clinically diagnosed Alzheimer's disease: a casecontrol study of an Italian population. Neurology 1986; 36: 922-931.
7. Hofman A, Schulte W, Tanja TA, van Duijn CM, Haaxma R, Lameris AJ, Otten VM, Saan RJ: History of dementia and Parkinson's disease in 1st-degree relatives of patients with Alzheimer's disease. Neurology 1989; 39: 1589-1592.
8. Stroup DF, Berlin JA, Morton SC, Olkin I, Williamson GD, Rennie D, Moher D, Becker BJ, Sipe TA, Thacker SB: Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-Analysis of Observational Studies in Epidemiology (MOOSE) group. JAMA 2000; 283: 2008-2012.
9. Susser E, Susser M: Familial aggregation studies: a note on their epidemiologic properties. Am J Epidemiol 1989; 129: 23-30.
10. DerSimonian R, Laird N: Meta-analysis in clinical trials. Control Clin Trials 1986; 7: 177-188.
11. Higgins JP, Thompson SG: Quantifying heterogeneity in a meta-analysis. Stat Med 2002; 21: 1539-1558.
12. Egger M, Davey Smith G, Schneider M, Minder C: Bias in meta-analysis detected by a simple, graphical test. BMJ 1997; 315: 629-634.
13. StataCorp: Stata: statistical software, release 12. College Station, StataCorp, 2011.
14. Huff FJ, Auerbach J, Chakravarti A, Boller F: Risk of dementia in relatives of patients with Alzheimer's disease. Neurology 1988; 38: 786-790.
15. Hemminki K, Sundquist K, Li X: Familial risks for main neurological diseases in siblings based on hospitalizations in Sweden. Twin Res Hum Genet 2006; 9: 580-586.
16. Costello S, Bordelon Y, Bronstein J, Ritz B: Familial associations of Alzheimer disease and essential tremor with Parkinson disease. Eur J Neurol 2010; 17: 871-878.
17. Levy G, Louis ED, Mejia-Santana H, Côté L, Andrews H, Harris J, Waters C, Ford B, Frucht S, Fahn S, Ottman R, Marder K: Lack of familial aggregation of Parkinson disease and Alzheimer disease. Arch Neurol 2004; 61: 1033-1039.
18. Marder K, Tang MX, Alfaro B, Mejia H, Côté L, Louis E, Stern Y, Mayeux R: Risk of Alzheimer's disease in relatives of Parkinson's disease patients with and without dementia. Neurology 1999; 52: 719-724.
19. Mickel SF, Broste SK, Hiner BC: Lack of overlap in genetic risks for Alzheimer's disease and Parkinson's disease. Neurology 1997; 48: 942-949.
20. Rocca WA, Bower JH, Ahlskog JE, Elbaz A, Grossardt BR, McDonnell SK, Schaid DJ, Maraganore DM: Risk of cognitive impairment or dementia in relatives of patients with Parkinson disease. Arch Neurol 2007; 64: 1458-1464.
21. Rosen AR, Steenland NK, Hanfelt J, Factor SA, Lah JJ, Levey AI: Evidence of shared risk for Alzheimer's disease and Parkinson's disease using family history. Neurogenetics 2007; 8: 263-270.
22. Fratiglioni L, Ahlbom A, Viitanen M, Winblad B: Risk factors for late-onset Alzheimer's disease: a population-based, case-control study. Ann Neurol 1993; 33: 258-266.
23. Kockler M, Nitardy A, Papassotiropoulos A, Ptok U, Maier W, Heun R: Physical disorders and causes of death in relatives of Alzheimer's disease patients. Int J Geriatr Psychiatry 2002; 17: 335-342.
24. Kurz M, Alves G, Aarsland D, Larsen JP: Familial Parkinson's disease: a communitybased study. Eur J Neurol 2003; 10: 159-163.
25. Li G, Shen YC, Li YT, Chen CH, Zhau YW, Silverman JM: A case-control study of Alzheimer's disease in China. Neurology 1992; 42: 1481-1488.
26. Silverman JM, Raiford K, Edland S, Fillenbaum G, Morris JC, Clark CM, Kukull W, Heyman A: The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part VI. Family history assessment: a multicenter study of first-degree relatives of Alzheimer's disease probands and nondemented spouse controls. Neurology 1994; 44: 1253-1259.
27. Suhanov AV, Pilipenko PI, Korczyn AD, Hofman A, Voevoda MI, Shishkin SV, Simonova GI, Nikitin YP, Feigin VL: Risk factors for Alzheimer's disease in Russia: a case-control study. Eur J Neurol 2006; 13: 990-995.
28. Elbaz A, McDonnell SK, Maraganore DM, Strain KJ, Schaid DJ, Bower JH, Ahlskog JE, Rocca WA: Validity of family history data on PD: evidence for a family information bias. Neurology 2003; 61: 11-17.
29. Hudson JI, Javaras KN, Laird NM, Vander-Weele TJ, Pope HG Jr, Hernán MA: A structural approach to the familial coaggregation of disorders. Epidemiology 2008; 19: 431-439.
30. Crews L, Tsigelny I, Hashimoto M, Masliah E: Role of synucleins in Alzheimer's disease. Neurotox Res 2009; 16: 306-317.
31. Ono K, Takahashi R, Ikeda T, Yamada M: Cross-seeding effects of amyloid β-protein and α-synuclein. J Neurochem 2012; 122: 883-890.
32. Braak H, del Tredici K, Rüb U, de Vos RA, Jansen Steur EN, Braak E: Staging of brain pathology related to sporadic Parkinson's disease. Neurobiol Aging 2003; 24: 197-211.
33. Braak H, Rüb U, del Tredici K: Cognitive decline correlates with neuropathological stage in Parkinson's disease. J Neurol Sci 2006; 248: 255-258.
34. Wirdefeldt K, Adami HO, Cole P, Trichopoulos D, Mandel J: Epidemiology and etiology of Parkinson's disease: a review of the evidence. Eur J Epidemiol 2011; 26(suppl 1):S1-S58.
35. Sharp ES, Gatz M: Relationship between education and dementia: an updated systematic review. Alzheimer Dis Assoc Disord 2011; 25: 289-304.
36. Frigerio R, Elbaz A, Sanft KR, Peterson BJ, Bower JH, Ahlskog JE, Grossardt BR, de Andrade M, Maraganore DM, Rocca WA: Education and occupations preceding Parkinson disease: a population-based case-control study. Neurology 2005; 65: 1575-1583.
37. Bertram L, McQueen MB, Mullin K, Blacker D, Tanzi RE: Systematic meta-analyses of Alzheimer disease genetic association stud - ies: the AlzGene database. Nat Genet 2007; 39: 17-23.
38. Lill CM, Roehr JT, McQueen MB, Kavvoura FK, Bagade S, Schjeide BM, Schjeide LM, Meissner E, Zauft U, Allen NC, Liu T, Schilling M, Anderson KJ, Beecham G, Berg D, Biernacka JM, Brice A, DeStefano AL, Do CB, Eriksson N, Factor SA, Farrer MJ, Foroud T, Gasser T, Hamza T, Hardy JA, Heutink P, Hill-Burns EM, Klein C, Latourelle JC, Maraganore DM, Martin ER, Martinez M, Myers RH, Nalls MA, Pankratz N, Payami H, Satake W, Scott WK, Sharma M, Singleton AB, Stefansson K, Toda T, Tung JY, Vance J, Wood NW, Zabetian CP, Young P, Tanzi RE, Khoury MJ, Zipp F, Lehrach H, Ioannidis JP, Bertram L: Comprehensive research synopsis and systematic meta-analyses in Parkinson's disease genetics: the PDGene database. PLoS Genet 2012; 8:e1002548.
39. Moskvina V, Harold D, Russo G, Vedernikov A, Sharma M, Saad M, Holmans P, Bras JM, Bettella F, Keller MF, Nicolaou N, Simón-Sánchez J, Gibbs JR, Schulte C, Durr A, Guerreiro R, Hernandez D, Brice A, Stefánsson H, Majamaa K, Gasser T, Heutink P, Wood N, Martinez M, Singleton AB, Nalls MA, Hardy J, Owen MJ, O'Donovan MC, Williams J, Morris HR, Williams NM: Analysis of genome-wide association studies of Alzheimer disease and of Parkinson disease to determine if these 2 diseases share a common genetic risk. JAMA Neurol 2013, E-pub ahead of print.